Wuxi Biologics Cayman - ADRWXXWY
13F holders, Q4 2025 (December 31)5holders +1
1new positions
0sold out
$8.04avg. 13F price*
At the end of Q4 2025, 5 institutions reported holding Wuxi Biologics Cayman - ADR (WXXWY) in their 13F filings, up 1 from Q3 2025. 1 opened new positions and 0 sold out. The largest holders were Rhumbline Advisers ($83K), PNC Financial Services Group, Inc. ($27K) and Westside Investment Management, Inc. ($19K).
- Company
- Wuxi Biologics Cayman - ADR
- CUSIP
- 98260N108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $144 |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 1,728 shares bought and 609 shares sold, net +1,119 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Rhumbline Advisers | 0.00% | Reduce -5.6% | 10,345 | $83K |
| PNC Financial Services Group, Inc. | 0.00% | Add +2.7% | 3,337 | $27K |
| Westside Investment Management, Inc. | 0.00% | No change | 2,229 | $19K |
| GAMMA Investing LLC | 0.00% | Add +633.6% | 1,878 | $15K |
| IMA Advisory Services, Inc. | 0.00% | New | 18 | $144 |
"% of holder's portfolio" is WXXWY's weight in each manager's 13F, not the share of Wuxi Biologics Cayman - ADR the manager owns.